Cardiac monitoring of patients receiving arsenic trioxide therapy.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced*; D015716:Electrocardiography, Ambulatory; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000009:adverse effects*; D011446:Prospective Studies
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide